Their ages were between 18 and 40. The authors' conclusion is that this combination of antigens has an acceptable level of safety and immunogenicity and stimulates memory T and merits additional clinical study.
La conclusión de los autores es que esta combinación de antígenos tiene una aceptable seguridad e inmunogenicidad, que estimula linfocitos T de memoria y amerita estudios clínicos adicionales.